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Abstract  17 
Clavulanic acid is an important drug, both medically and economically. It is used to combat bacterial resistance 18 
to β-lactam antibiotics and is on the World Health Organisation’s List of Essential Medicines in combination with 19 
amoxicillin. An olive oil industry waste product, olive pomace oil (OPO), is a potential alternative carbon source 20 
for clavulanic acid production by Streptomyces clavuligerus. Olive pomace oil is six times cheaper than glycerol, 21 
which is the current industry standard. The aims of this study were to examine if olive pomace oil can be used as 22 
a carbon source for clavulanic acid production and to compare the clavulanic acid yield achieved in shake flasks 23 
and 1.8 L bioreactors. It was observed that olive pomace oil was efficiently utilised as a sole carbon source by S. 24 
clavuligerus growing in a P-limited medium. The S. clavuligerus cells grew faster in olive pomace oil-containing 25 
cultures compared to the glycerol-containing cultures (control) and produced comparable levels of clavulanic acid, 26 
but much earlier. In cultures with ISP2 medium that contained glycerol or olive pomace oil, higher levels of 27 





































































clavulanic acid were obtained in shake flask cultures with olive pomace oil. Interestingly, the same levels of 28 
clavulanic acid were observed in oil-containing cultures in bioreactors, but 48 h earlier. Furthermore, the oil-29 
containing cultures did not need addition of an antifoam agent, while higher levels of cell viability were 30 
maintained after 72 h in these fermentations compared to the cultures that contained glycerol. Our results suggest 31 
that olive pomace oil can replace glycerol for clavulanic acid production in S. clavuligerus fermentations, which 32 
will significantly increase the productivity and cut the cost for industrial clavulanic acid biosynthesis. The same 33 
carbon source can be tested in other similar fermentation approaches for the production of antibiotics or other 34 
valuable bioproducts.  35 
 36 
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 38 
Statement of Novelty 39 
Olive pomace oil is an environmentally toxic waste of the olive oil industry. We show that it can replace glycerol 40 
in microbial fermentations, leading to higher yield of clavulanic acid production.  41 
 42 
Introduction 43 
The most common mechanism by which bacteria acquire resistance to beta-lactam antibiotics is through the 44 
production of beta-lactamase enzymes. These enzymes cleave the beta-lactam rings of important antibiotics such 45 
as penicillins and cephalosporins, leading to their inactivation. Clavulanic acid, produced by Streptomyces 46 
clavuligerus, is used in conjunction with β-lactam antibiotics, acting as a suicide inhibitor that protects these drugs 47 
from the β-lactamases of resistant bacteria [1]. The combination of amoxicillin and clavulanic acid is on the World 48 
Health Organisation (WHO) list of essential medicines [2]. Due to the importance of this treatment, much research 49 
has been done to improve the growth of S. clavuligerus, and the organism’s production of clavulanic acid [3]. 50 
Different from most organisms, S. clavuligerus lacks a glucose transport system [4], so it is unable to utilise this 51 
sugar. Instead, glycerol is the most popular carbon source used for industrial production of clavulanic acid [5]. 52 
Glycerol is, however, relatively expensive, so cheaper alternatives such as oils have been looked into. It has been 53 




































































acid being produced by S. clavuligerus, with olive oil producing a maximum concentration of 47 mg L-1, almost 55 
double that of the standard glycerol (25 mg L-1) [6]. 56 
Olive mills generate huge waste in short periods of time, which is seen as an environmental problem for 57 
Mediterranean countries [7]. These wastes have high phytotoxicity, with studies also showing adverse effects on 58 
soil microbial populations [8] and aquatic ecosystems [9]. While olive oil is cheaper than glycerol, and has been 59 
shown to work better, it does not seem ethical to add to existing demand, and in turn, increasing waste. One of 60 
these wastes from the olive oil industry, olive pomace oil (OPO) [10], has its own potential as a carbon source for 61 
S. clavuligerus. Miranda et al. [11] show that there is around 52% carbon composition in the pomace, while the 62 
pulp (where regular olive oil is obtained) has around 55%. This suggests that OPO likely has sufficient energy to 63 
be a viable carbon source, still outperforming glycerol as olive oil was shown to. The average price of OPO is 64 
£1.50 per L, which is six times less expensive than the standard carbon source glycerol (£9 per L). In addition to 65 
being cost effective, OPO utilisation would also create a positive reuse for some of the vast amounts of waste 66 
found in the olive oil industry. If accepted widely, this could bring huge economic and environmental benefits to 67 
Mediterranean countries, and lower costs for clavulanic acid producers. Additionally, oil has natural anti-foaming 68 
properties and can enhance secondary metabolism [12].  69 
Lots of efforts have been devoted to the development of S. clavuligerus strains with the aim to improve the 70 
production of clavulanic acid. These strain improvements, whether they were done through random mutagenesis 71 
[13] or targeted modification of metabolic pathways [14], were usually carried out with glycerol in mind as the 72 
carbon source. With food oils already yielding higher clavulanic acid production, and in some cases culture 73 
growth, strain improvement of S. clavuligerus to increase the utilisation of these oils [15] could greatly improve 74 
clavulanic acid production. 75 
Although complex media are commonly used for industrial clavulanic acid production, defined media allow us to 76 
test varying media ingredients. In this paper, we used defined media to test the growth of S. clavuligerus and the 77 
yield of clavulanic acid using OPO as the sole carbon source. To assess the fermentation efficiency of different 78 
carbon sources, glycerol was set as control to produce clavulanic acid. Because of the high carbon content, we 79 
hypothesise that OPO will prove to be a suitable carbon source, likely more effective than the industry standard 80 
of glycerol for clavulanic acid production. In addition, we believe that OPO will continue to be effective at higher 81 





































































Materials and Methods 84 
Strains and media 85 
The bacterial strain used in this study was Streptomyces clavuligerus DM738 (kindly provided by Prof. Paul 86 
Hoskisson, University of Strathclyde, UK). The medium used for the pre-culture was SV2, containing (per L): 87 
Glycerol, 15 g; Glucose, 15 g; Peptone, 15 g; CaCO3, 1 g. For the flask cultures, a P-limited medium was used, 88 
containing (per L): NH4Cl, 7 g; KH2PO4, 0.25 g; MOPS, 21 g. The pH value was adjusted to 6.8 and the medium 89 
was autoclaved at 121°C for 15 min. 10 mL of trace elements stock solution was aseptically added per L of P-90 
limited medium after autoclaving [6]. The trace elements stock solution contained (per L): MgSO4.7H20, 25 g; 91 
FeSO4.7H2O, 2.5 g; CoCl2, 0.055 g; CuCl2 0.053 g, CaCl2.2H2O, 1.4 g; ZnCl2, 1 g; MnCl2, 1 g; Na2MoO4, 0.03 92 
g. For shake flask and bioreactor cultures, ISP2 medium was used, containing (per L): Yeast extract, 4 g; Malt 93 
extract, 10 g; Dextrose, 4 g. The carbon source was added at 0.6% v/v by filter sterilisation. All media were 94 
autoclaved at 121°C for 15 min unless stated otherwise. 95 
 96 
Inoculum preparation and cultures 97 
For the pre-culture, 1 mL of spores was added into 50 mL of SV2 in a 250 mL glass baffled flask and agitated at 98 
200 rpm at 30°C for 48 h. The culture was transferred into plastic universals and centrifuged at 6000 xg for 5 min. 99 
The supernatant was removed, and the pellets were resuspended in 6 mL of P-limited media. For the shake flask 100 
experiments, 2 L glass baffled flasks were used containing 400 mL of medium (P-limited or ISP2). Each flask 101 
was inoculated with 1 mL of the re-suspended inoculum. The flasks were incubated at 30°C, with agitation at 150 102 
rpm.  103 
For the bioreactor cultures, 1.8 L bioreactors (DASGIP parallel system, Eppendorf, UK) were used. Each vessel 104 
contained 1 L of ISP2 medium. The inoculum was prepared as described above and introduced aseptically with a 105 
syringe (5% v/v). The agitation rate was set at 1000 rpm, with a culturing temperature of 30°C. The pH value was 106 
maintained at 7 and the aeration rate was set at 0.25 L min-1. OPO or glycerol were added at the same percentage 107 
as above. Filter-sterilised Antifoam 204 (Sigma-Aldrich, UK) was added at 0.001% v/v in the glycerol-containing 108 
cultures. 109 
 110 




































































Clavulanic acid levels were determined as described by Bird et al. [16]. 112 
 113 
Biomass determination 114 
Biomass levels were determined as described by Efthimiou et al. [6].  115 
 116 
Results and Discussion 117 
Production of many secondary metabolites by Streptomyces species, including clavulanic acid, are negatively 118 
regulated by phosphate [17]. P-limited media is thus often used to stimulate the production of these compounds. 119 
As can be seen in Figure 1A, in P-limited medium, S. clavuligerus reached maximal growth five days earlier than 120 
in the oil-containing cultures compared to the glycerol containing cultures. The OPO cultures also produced higher 121 
levels of clavulanic acid until 264 h with a maximum clavulanic acid concentration of nearly 150 mg L-1. The 122 
maximum clavulanic acid production in the glycerol cultures was over 200 mg L-1, however this decreased later. 123 
These results are a good first indication that OPO could be a suitable carbon source replacement for clavulanic 124 
acid production in S. clavuligerus. It should be noted that the method of inoculation ensures a minimal carry over 125 
of nutrients. 126 
Once it was determined that OPO was able to be utilised in a defined medium, it was then added as a carbon 127 
source in a complex media (Figures 2A and 2B), which more accurately replicates the conditions in industrial 128 
productions (albeit at a laboratory scale). In the first 24 h of growth in complex media, OD values obtained were 129 
very similar between the carbon sources, but OPO cultures achieved higher growth at all time points recorded. In 130 
addition, Figure 2B shows that OPO as a carbon source in complex media again led to the production of much 131 
larger amounts of clavulanic acid (over double that of glycerol at 48 h). This is similar to previous results obtained 132 
comparing clavulanic acid production in olive oil and glycerol [6, 18]. Cell viability was also greater in OPO 133 
cultures across all experiments when spread onto plates (data not shown). 134 
The next step was to scale up the experiment to 1.8 L bioreactors, further replicating industrial production. Figure 135 
2C continues to support OPO as a superior carbon source to glycerol, with the OPO cultures obtaining a higher 136 




































































also occurs earlier in OPO cultures with a maximum of 325 mg L-1 at 48 h. This is achieved 48 hours earlier than 138 
the maximum 350 mg L-1 found in glycerol cultures. 139 
Using data from the bioreactor cultures, Table 1 shows that OPO outcompetes glycerol in all four aspects 140 
measured: growth yield, growth rate, clavulanic acid yield, clavulanic acid rate. Growth yield and growth rate 141 
values from OPO cultures were almost double that of glycerol cultures. Clavulanic acid yield between carbon 142 
sources was closer, but OPO still appears the more favourable than glycerol (59.96 mg g-1 of carbon source and 143 
46.16 mg g-1 of carbon source, respectively). Similarly, the rate of clavulanic acid production was 1.47 times 144 
higher in OPO cultures than in glycerol cultures. 145 
The effectiveness of OPO also has the potential to drastically increase through strain improvement targeted 146 
specifically at the use of this carbon source. Industrial strains reportedly have a clavulanic acid production nearing 147 
3 g L-1 which is far higher than wild type strains (around 25-120 mg L-1) [3]. Spontaneous mutations with oil as a 148 
carbon source have been recorded [19], proving that this is viable. In combination with targeted mutagenesis, 149 
there is an even greater potential for OPO. It would be interesting to see the levels of clavulanic acid produced by 150 
these industrial strains when OPO is the carbon source. 151 
It was also observed in these experiments that OPO acted as a strong antifoam, leading to negligible foaming of 152 
the media compared to glycerol. This might partly explain the better results of OPO in the shake flask experiments 153 
(antifoam was added to glycerol cultures in the bioreactor experiments). Foam in the glycerol cultures may have 154 
impeded on gas exchange, negatively impacting on growth and clavulanic acid production [20]. Foam is generally 155 
seen as undesirable in the production of antibiotics [21]. 156 
All three of these experiments indicate that OPO is a superior carbon source as it led to faster growth, faster 157 
clavulanic acid production, and removed the need for an antifoam – an additional cost when glycerol is used. In 158 
other studies, fed-batch cultures have been shown to further increase the levels of clavulanic acid production [22]. 159 
This by-product of the olive oil industry is extracted from undesirable waste such as the skin, pulp, stone, and 160 
kernel of olives [23]. By providing these waste products with a use, OPO extraction both alleviates environmental 161 
pollution and can provide a further source of revenue for olive oil-producing countries. This has the potential to 162 
boost the economies of Spain, Greece, Italy, and other Mediterranean countries. OPO as a carbon source could 163 
also be of great economic impact for clavulanic acid producers as a result of its low cost of around £1.50 per L 164 




































































There are disadvantages that should be taken into account. First, there is often oil residue at the end of the culture 166 
due to limited interaction of the bacteria and the lipid droplets [12]. However, this problem is often countered by 167 
slowly deeding the oil during culture [24]. Secondly, there is often a greater oxygen demand in cultures with oils 168 
compared to carbohydrates [12]. 169 
In conclusion, our study shows that OPO is an effective carbon source for clavulanic acid production by S. 170 
clavuligerus fermentation. This extremely cheap by-product of the olive oil industry outperformed the standard 171 
carbon source, glycerol, by promoting faster growth, larger quantities of clavulanic acid production, and natural 172 
antifoaming properties. We believe that by switching to OPO, industrial producers could save large amounts of 173 
money, while at the same time achieving higher clavulanic acid yield. This would not only hugely benefit the 174 
Mediterranean countries that produce OPO, but reduce production costs of clavulanic acid, bringing the price 175 
down of an essential drug. Finally, it is possible that the same carbon source can be used in other similar 176 
fermentation approaches for the production of antibiotics or other valuable bioproducts. 177 
 178 
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Table Legend 250 
Table 1 Biomass and clavulanic acid production yields and rates (curve slope values), with olive pomace oil and 251 
























































































Figure Legends 273 
Figure 1 Growth (A) and clavulanic acid production (B) in shake flasks with P-limited medium and glycerol (gray 274 
line) or olive pomace oil (black line) as sole carbon source (n = 3, where n is the number of biological replicates). 275 
CLA: clavulanic acid. Error bars: ± Standard Deviation. 276 
Figure 2 Growth (A) and clavulanic acid production (B) in shake flasks with ISP2 and glycerol (gray line) or 277 
olive pomace oil (black line) as additional carbon source. Growth (C) and clavulanic acid production (D) in 1.8 L 278 
DASGIP bioreactors with ISP2 and glycerol or olive pomace oil as additional carbon source (n = 3, where n is the 279 
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